Marked effect of larotrectinib on primary cutaneous secretory carcinoma: A case report.

Autor: Hayakawa K; Department of Dermatology, Tokyo Medical University, Tokyo, Japan., Irisawa R; Department of Dermatology, Tokyo Medical University, Tokyo, Japan., Umefune R; Department of Dermatology, Tokyo Medical University, Tokyo, Japan., Mae K; Department of Dermatology, Tokyo Medical University, Tokyo, Japan., Shimada Y; Department of Thoracic and Thyroid Surgery, Tokyo Medical University, Tokyo, Japan., Takahashi R; Department of Pathology, Tokyo Medical University, Tokyo, Japan., Nagao T; Department of Pathology, Tokyo Medical University, Tokyo, Japan., Harada K; Department of Dermatology, Tokyo Medical University, Tokyo, Japan.
Jazyk: angličtina
Zdroj: The Journal of dermatology [J Dermatol] 2024 Sep; Vol. 51 (9), pp. e306-e307. Date of Electronic Publication: 2024 Apr 11.
DOI: 10.1111/1346-8138.17218
Databáze: MEDLINE